Ambulatory Surgery for Urogenital Prolapse : a Pilot Study
PCAP
1 other identifier
interventional
157
0 countries
N/A
Brief Summary
Main objective is evaluation of success rate of ambulatory surgery (AS) for pelvic organ prolapse (POP). All surgical approaches (laparoscopic, vaginal) are included in the study. Secondary objectives are AS rate in the overall population and reasons for ineligibility or failure of ambulatory surgery. This pilot study will evaluate the feasibility of AS for POP and identify pitfalls in AS. A randomized control study will follow PCAP study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 5, 2016
CompletedFirst Posted
Study publicly available on registry
October 6, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedFebruary 9, 2021
February 1, 2021
1 year
October 5, 2016
February 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success rate of ambulatory surgery in patient operated for urogenital prolapse
Success rate = (number of patients with period of hospitalization \< 12 hours)/ (number of patients operated for prolapsus)
After the 2 years of recruitment
Study Arms (1)
Ambulatory surgery
EXPERIMENTALAll the patients operated for pelvic organ prolapse during the study time will be recruited. All the patient eligible for an Ambulatory surgery will be discharged earlier.
Interventions
All patients who accepting participation to the study and operated for prolapse surgery, Patient eligible for Ambulatory surgery and return home on the same day if delivery criteria are satisfied ( Chung criteria+tsuccessful trial of void) Patient not eligible for Ambulatory surgery are included as control group
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- Planned POP surgery
- Valid social insurance
- French spoken and written
- Informed consent signed
You may not qualify if:
- Refuse participation to study
- Pregnant or lactating woman
- Vulnerable people (Article L 1121-6 of the french code of public health)
- Major subject to legal protection or unable to consent (Article 1121-8 of the french code of public health )
- Participation in another protocol for less than 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe Courtieu
Clinique Beau Soleil
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2016
First Posted
October 6, 2016
Study Start
August 1, 2015
Primary Completion
August 1, 2016
Study Completion
April 1, 2018
Last Updated
February 9, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share